Antiemetic Drugs Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET INTRODUCTION

Antiemetics are therapeutic agents that are effective against vomiting and nausea. These symptoms are of several medical conditions such as motion sickness, pregnancy, dizziness, emotional stress, food poisoning and among others. Additionally, they are also used to treat side effects of other medications including opioid analgesics, chemotherapy and general anesthetics.

MARKET DYNAMICS

Increasing number of patients suffering from cancer and increased number of surgeries and extensive research activities to revolutionize antiemetic drug therapy are major factors for market growth. Moreover, identification of new drug targets will positively influence market growth.

MARKET SCOPE

The "Antiemetic Drugs Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of antiemetic drugs market with detailed market segmentation by drug type and application. The antiemetic drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in antiemetic drugs market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The antiemetic drugs market is segmented on the basis of drug type and application. Based on drug type, the market is segmented as 5-HT3 receptor antagonists, dopamine antagonists, NK1 receptor antagonist, antihistamines, cannabinoids, benzodiazepines, anticholinergics, and others. By application, the market is segmented as chemotherapy, motion sickness, gastroenteritis, opioid analgesics, dizziness, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the antiemetic drugs market based onvarious segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The antiemetic drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting antiemetic drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the antiemetic drugs market in these regions.

MARKET PLAYERS

The report covers key developments in the antiemetic drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from antiemetic drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for antiemetic drugs in the global market. Below mentioned is the list of few companies engaged in the antiemetic drugs market.

The report also includes the profiles of key players in antiemetic drugs market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and drug type and application s offered, financial information of last 3 years, key development in past five years.

•   GLAXOSMITHKLINE PHARMACEUTICALS LIMITED
  
•   JOHNSON AND JOHNSON
  
•   SANOFI
  
•   MERCK AND CO.
  
•   NOVARTIS AG
  
•   BRISTOL-MYERS SQUIBB
  
•   ASTELLAS PHARMA, INC.
  
•   ELI LILLY AND COMPANY
  
•   ABBOTT, CIPLA LTD.
  
•   DR. REDDY'S LABORATORIES LTD
  

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Antiemetic Drugs Report Scope